{"product_id":"luciviga-vigabatrin","title":"LuciViga (Vigabatrin)","description":"\u003ch2\u003eAbout Vigabatrin\u003c\/h2\u003e\u003cp\u003eVigabatrin is used alone or together with other medicines to treat refractory complex partial seizures in adults and children 2 years of age and older, and infantile spasms in children. It is used in patients who have already been treated with other medicines that did not work well. Vigabatrin is an anticonvulsant.\u003c\/p\u003e\u003ch3\u003ePartial Seizures\u003c\/h3\u003e\u003cp\u003eIndicated as adjunctive therapy for refractory complex partial seizures in patients who have inadequately responded to several seizure treatments and for whom the potential benefits of vigabatrin outweigh the risk of vision loss\u003c\/p\u003e\u003cp\u003e500 mg PO q12hr initially, THEN increase by 500-mg increments qWeek to target dose of 1.5 g q12hr\u003c\/p\u003e\u003cp\u003eNo additional benefit shown with 6 g daily compared with 3 g daily; higher incidence of adverse effects associated with 6 g daily\u003c\/p\u003e\u003ch3\u003eDosage Modifications\u003c\/h3\u003e\u003ch4\u003eRenal impairment\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eMild (CrCl \u0026gt;50 to 80 mL\/min): Decrease dose by 25%\u003c\/li\u003e\n\u003cli\u003eModerate (CrCl \u0026gt;30 to 50 mL\/min): Decrease dose by 50%\u003c\/li\u003e\n\u003cli\u003eSevere (CrCl \u0026gt;10 to 30 mL\/min): Decrease dose by 75%\u003c\/li\u003e\n\u003cli\u003eHemodialysis: Clearance not adequately studied\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Lucius Pharmaceuticals (Lao) Co., Ltd","offers":[{"title":"Default Title","offer_id":44797955440683,"sku":"RL3120250101","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2024-12-093.jpg?v=1787022232","url":"https:\/\/xomeds.com\/products\/luciviga-vigabatrin","provider":"XOMEDS","version":"1.0","type":"link"}